Elanco Animal Health Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 106 trades in Elanco Animal Health (NYSE: ELAN) since 2018, across 10 members, worth an estimated $2.3M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 55 buys against 47 sells, a modestly buy-led skew, with Democratic members responsible for 85% of the trades and Republican members 15%. The most recent disclosure shown was filed December 2025, and Ro Khanna has filed the most ELAN transactions among those shown, with 8. Other recent filers include Valerie Hoyle. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Elanco Animal Health (ELAN) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Elanco Animal Health congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
 Ro Khanna House | Dec 8, 2025 | Nov 4, 2025 | 34 days | SELL |  $1,001 - $15,000 | +9.20% | |
Ro Khanna House | Dec 8, 2025 | Nov 3, 2025 | 35 days | SELL | $1,001 - $15,000 | +7.53% | |
Ro Khanna House | Nov 6, 2025 | Oct 29, 2025 | 8 days | SELL | $1,001 - $15,000 | +8.76% | |
Ro Khanna House | Nov 6, 2025 | Oct 27, 2025 | 10 days | SELL | $1,001 - $15,000 | +10.33% | |
 Valerie Hoyle House | Oct 10, 2025 | Sep 23, 2025 | 17 days | SELL | $1,001 - $15,000 | +32.52% | |
Ro Khanna House | Oct 3, 2025 | Sep 22, 2025 | 11 days | SELL | $1,001 - $15,000 | +29.11% | |
Ro Khanna House | Sep 9, 2025 | Aug 27, 2025 | 13 days | SELL | $1,001 - $15,000 | +32.88% | |
Ro Khanna House | Jul 9, 2025 | Jun 26, 2025 | 13 days | SELL | $50,001 - $100,000 | +71.82% | |
Ro Khanna House | Jul 9, 2025 | Jun 10, 2025 | 29 days | SELL | $15,001 - $50,000 | +71.82% |
Elanco Animal Health (ELAN) congressional trading FAQ
Can members of Congress legally trade Elanco Animal Health (ELAN) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Elanco Animal Health (ELAN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional Elanco Animal Health (ELAN) trades public?
Yes. Every congressional trade in Elanco Animal Health (ELAN) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Elanco Animal Health (ELAN)?
Members of Congress have disclosed 106 trades in Elanco Animal Health (ELAN) worth $2.3M across 10 members, according to public STOCK Act filings.
Which members of Congress have traded Elanco Animal Health (ELAN)?
Recent and active filers of Elanco Animal Health (ELAN) disclosures include Ro Khanna, Valerie Hoyle. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Elanco Animal Health (ELAN) more?
Across disclosed Elanco Animal Health (ELAN) trades, 85% were by Democrats and 15% by Republicans, led by Democrats (85%).
What is the most recent congressional Elanco Animal Health (ELAN) trade?
The most recent disclosed Elanco Animal Health (ELAN) trade was a sale by Ro Khanna, filed Dec 7, 2025.
Browse all stocks Congress tradesCongressional trading overviewElanco Animal Health (ELAN) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.